DE69026077T2 - Medizinische verwendung von m-csf - Google Patents

Medizinische verwendung von m-csf

Info

Publication number
DE69026077T2
DE69026077T2 DE69026077T DE69026077T DE69026077T2 DE 69026077 T2 DE69026077 T2 DE 69026077T2 DE 69026077 T DE69026077 T DE 69026077T DE 69026077 T DE69026077 T DE 69026077T DE 69026077 T2 DE69026077 T2 DE 69026077T2
Authority
DE
Germany
Prior art keywords
csf
medical use
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69026077T
Other languages
English (en)
Other versions
DE69026077D1 (de
Inventor
Gideon Strassmann
Satoru Nakai
Masayuki Takahashi
Hiroyuki Ichikawa
Yoshikatsu Hirai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69026077D1 publication Critical patent/DE69026077D1/de
Publication of DE69026077T2 publication Critical patent/DE69026077T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE69026077T 1989-12-13 1990-12-12 Medizinische verwendung von m-csf Expired - Fee Related DE69026077T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP32351889 1989-12-13
US51775290A 1990-05-02 1990-05-02
PCT/JP1990/001629 WO1991008754A1 (en) 1989-12-13 1990-12-12 Medicinal application of m-csf
AU77379/91A AU637909B2 (en) 1989-12-13 1991-05-28 Medical uses of m-csf

Publications (2)

Publication Number Publication Date
DE69026077D1 DE69026077D1 (de) 1996-04-25
DE69026077T2 true DE69026077T2 (de) 1996-10-17

Family

ID=27156236

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69026077T Expired - Fee Related DE69026077T2 (de) 1989-12-13 1990-12-12 Medizinische verwendung von m-csf

Country Status (7)

Country Link
EP (1) EP0456842B1 (de)
JP (1) JPH0653673B2 (de)
AU (1) AU637909B2 (de)
DE (1) DE69026077T2 (de)
DK (1) DK0456842T3 (de)
ES (1) ES2086526T3 (de)
WO (1) WO1991008754A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU676227B2 (en) * 1993-01-22 1997-03-06 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Therapeutic agent for NIDDM
EP0663211A4 (de) * 1993-03-17 1997-07-09 Otsuka Pharma Co Ltd Mittel zur verhütung und behandlung von krankheiten der schleimhäute des verdauungstraktes.
IT1276213B1 (it) * 1995-10-06 1997-10-27 Mendes Srl Composizioni dermatologiche e cosmetiche atte all'applicazione topica, ad effetto modulante sulle ceramidi endogene dell'epidermide
CN1226833A (zh) * 1996-05-31 1999-08-25 三共株式会社 自身免疫疾病治疗剂
US20140030218A1 (en) * 2011-01-05 2014-01-30 Imperial Innovations Limited Treatment And Screening
JP6251516B2 (ja) * 2012-10-24 2017-12-20 株式会社ダイセル 皮膚感作性物質の検出方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2583770B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子
AU625807B2 (en) * 1987-09-22 1992-07-16 Novartis Vaccines And Diagnostics, Inc. Uses of recombinant colony stimulating factor-1
US4961926A (en) * 1987-11-19 1990-10-09 Sloan-Kettering Institute For Cancer Research Methods for prevention and treatment of mucositis with granulocyte colony stimulating factor
JPH0610137B2 (ja) * 1988-02-29 1994-02-09 新技術事業団 ヒト単球−マクロファージコロニー刺激因子を有効成分とする造血器疾患治療剤
US5021239A (en) * 1988-03-21 1991-06-04 Genetics Institute, Inc. Use of M-CSF to improve lipoprotein cholesterol profiles

Also Published As

Publication number Publication date
EP0456842A4 (en) 1992-07-22
AU637909B2 (en) 1993-06-10
WO1991008754A1 (en) 1991-06-27
EP0456842A1 (de) 1991-11-21
JPH0653673B2 (ja) 1994-07-20
DE69026077D1 (de) 1996-04-25
ES2086526T3 (es) 1996-07-01
DK0456842T3 (da) 1996-04-15
AU7737991A (en) 1992-12-17
EP0456842B1 (de) 1996-03-20

Similar Documents

Publication Publication Date Title
ATA98488A (de) Pharmazeutische verwendung von 17-ketosteroiden
DK376589A (da) Engangssproejte
DE69028109T2 (de) Medizinische beatmungsgeräte
IT8848710A0 (it) Siringa monouso
BR9007526A (pt) Seringa hipodermica descartavel
DE69033636T2 (de) Verwendung von 4-Acyloxychinolin-Derivate als Insektizide und Akarizide
BR8900666A (pt) Aboservente catamenial descartavel
DE69026077D1 (de) Medizinische verwendung von m-csf
KR900701341A (ko) 일회용 주사기
KR900015532U (ko) 일부인
ATA254988A (de) Einwegspritze
DK286889D0 (da) Injektionssproejte
DE59003265D1 (de) Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica.
IT8847653A0 (it) Sizzante comprendente 5 - idroscomposizione farmaceutica anoressitrpofano
DK242989D0 (da) Engangssproejte
ATA49889A (de) Pharmazeutische verwendung von agmatin
DE3777432D1 (de) Verwendung von 2-aminoalkyl-5-pyridinol-verbindungen als nootropika und antidepressiva.
ATA244088A (de) Einwegspritze
FI88869C (fi) Anordning foer foerflyttning av patient
KR900014258U (ko) 의료용 주사기
DK402689D0 (da) Engangssproejte
BR6900509U (pt) Seringa descartavel
KR910008655U (ko) 1회용 주사기
IT8968151A0 (it) Siringa monouso
KR910008656U (ko) 1회용 주사기

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee